Do you want to read an article? Please log in or register.
One Anastomosis Gastric Bypass/Minigastric Bypass in Patients with BMI < 35 kg/m2 and Type 2 Diabetes Mellitus: Preliminary Report
Type 2 DiabetesObesity and Bariatric Surgery
Related content
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study
Diabetes Care.
Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB
doi: 10.2337/dc17-0487.
COMMENTED
Obesity and Bariatric Surgery
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial
Lancet.
Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, Poghosyan T, Chevallier JM, Malherbe V, Chouillard E, Reche F, Torcivia A, Maucort-Boulch D, Bin-Dorel S, Langlois-Jacques C,
Delaunay D, Pattou F, Disse E
doi: 10.1016/S0140-6736(19)30475-1.
COMMENTED
Obesity and Bariatric Surgery
Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study
Diabetologia.
Madsen LR, Baggesen LM, Richelsen B, Thomsen RW
doi: 10.1007/s00125-019-
COMMENTED
Type 2 DiabetesObesity and Bariatric Surgery
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Hofsø D, Fatima F, Borgeraas H, Birkeland KI, Gulseth HL, Hertel JK, Johnson LK, Lindberg M, Nordstrand N, Cvancarova Småstuen M, Stefanovski D, Svanevik M, Gretland Valderhaug T, Sandbu R, Hjelmesæth J
doi: 10.1016/S2213-8587(19)30344-4.
Type 2 Diabetes
Weight loss in patients with type 2 diabetes (T2D) mellitus receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: An AWARD-4 post-hoc analysis across baseline body mass index subgroups
Diabetes Obes Metab.
Fuechtenbusch M, Aberle J, Heitmann E, Nicolay C, Jung H
doi: 10.1111/dom.
COMMENTED
Type 2 Diabetes
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Diabetes Care.
Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG
doi: 10.2337/dc18-0431.
Obesity and Bariatric Surgery
Obesity alters composition and diversity of the oral microbiota in patients with type 2 diabetes mellitus independently of glycemic control
PLoS One.
Tam J, Hoffmann T, Fischer S, Bornstein S, Gräßler J, Noack B
doi: 10.1371/journal.pone.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials
Diabetes Technol Ther.
Sun D, Zhang X, Hou XX
doi: 10.1089/dia.2018.0132.
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.